Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical In
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. engages in the biopharmaceutical development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.

Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded on March 21, 1997 and is headquartered in Novato, CA.

Number of employees : 2 293 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Development & Commercialization of Innovative Therapies889.90101.9%1,117100.6% +25.5%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States444.0850.8%507.5445.7% +14.29%
Europe178.7520.5%252.6322.7% +41.34%
Latin America142.3116.3%147.4713.3% +3.63%
Rest of World124.7714.3%209.2118.8% +67.68%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé632005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA582012Chief Financial Officer & Executive Vice President
Henry J. Fuchs, MD592009Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Elaine J. Heron PhD, MBA692002Independent Non-Executive Director
Michael G. Grey642005Independent Non-Executive Director
Richard A. Meier572006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD652007Independent Non-Executive Director
Alan J. Lewis, PhD712005Independent Non-Executive Director
Dennis Joseph Slamon MD, PhD682014Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 173,352,133 172,676,283 99.6% 0 0.0% 99.6%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 19,643,043 11.4%
The Vanguard Group, Inc. 13,207,286 7.64%
Jennison Associates LLC 9,871,207 5.71%
Sands Capital Management LLC 9,380,802 5.43%
BlackRock Fund Advisors 8,661,674 5.01%
PRIMECAP Management Co. 7,885,948 4.56%
Fidelity Management & Research Co. 7,543,465 4.36%
Baker Bros. Advisors LP 4,806,483 2.78%
SSgA Funds Management, Inc. 3,743,112 2.17%
Temasek Holdings Pte Ltd. (Investment Management) 3,472,712 2.01%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6678.03%13,000,001 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICA..15.74%16 614
BIOGEN INC3.78%57 528
CSL LIMITED32.01%44 939
ALEXION PHARMACEUTICAL..4.44%28 694
GRIFOLS SA30.88%17 025
CHONGQING ZHIFEI BIOLO..--.--%4 853
BEIJING TIANTAN BIOLOG..16.22%3 426
3SBIO INC36.58%3 381
JIANGXI BOYA BIO-PHARM..--.--%2 315
ABCAM PLC11.73%2 261
HUGEL INC--.--%1 347
PROMETIC LIFE SCIENCES..-5.26%1 057
BIOTEST AG76.10%1 028
PHARMA MAR SA27.68%852
ANIKA THERAPEUTICS INC-5.78%675
SYROS PHARMACEUTICALS ..24.92%356
CHEMOCENTRYX INC-2.16%349
SYNDAX PHARMACEUTICALS..32.36%173
STRONGBRIDGE BIOPHARMA..87.50%159
STEADYMED LTD176.92%145
KADMON HOLDINGS INC-48.60%143
Sector Biopharmaceuticals
BioMarin Pharmaceutical In : Connections
Reneo Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc.
Selventa, Inc.
Translational Research In Oncology
Balance Therapeutics, Inc.
Batu Biologics, Inc.
Biothera, Inc.
Zephyrus Biosciences, Inc.
Capella Therapeutics, Inc.
Itero Biopharmaceuticals LLC
Jonsson Comprehensive Cancer Center
AbSci LLC
Cellastra, Inc.
Ziarco Group Ltd.
Biotechnology Innovation Organization
Sosei Co. Ltd.
Reform Biologics LLC
Rincon Pharmaceuticals, Inc.
Rapidscan Pharma Solutions, Inc.
Targazyme, Inc.
Sutro Biopharma, Inc.
Scancell Ltd.
DiaVacs, Inc.
University of California, Los Angeles
Cytochroma, Inc.
David Geffen School of Medicine
Company contact information
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415 506 6700
Fax : +1 415 382 7889
Internet : http://www.bmrn.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- ISIN Code :  US09061G1013
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem